{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:31:58Z","timestamp":1791433918488,"version":"4.3.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008977","name":"Universit\u00e4t Ulm","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008977","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Approximately 7% of adults develop Post-COVID-19 syndrome (PCS). Cognitive impairment is common, but its profile in PCS is not well defined and requires clearer differentiation from general (post-)illness effects. The aim of this study was to identify distinct cognitive profiles in PCS and to characterize them with respect to broader psychological factors such as fatigue, depression, anxiety, and personality. To this end, we assessed cognition, fatigue, depression, anxiety, and personality traits in PCS patients, convalescents (CV), healthy controls (HC), and post-viral syndrome patients (PV) of different etiology. Cognitive performance was assessed with an extensive protocol covering multiple cognitive domains, including verbal and nonverbal short-term memory, verbal and nonverbal working memory, verbal and nonverbal episodic memory, visuoconstruction, attentional functions, and executive functions, alongside patient-reported measures of fatigue, depression, anxiety, and personality, as well as self-reported information on lifetime psychiatric diagnoses. Group comparisons and discriminant analysis (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u2009.065) identified the tests that best differentiate the groups, while exploratory cluster analysis allowed for data-driven group assignment. In this study,\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u200954 PCS,\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u200942 HC,\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u200925 CV, and\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u200912 PV were included. Patients with PCS show low mean scores and cluster into two subgroups: 7.5% with severe objective cognitive impairments (PCS\n                    <jats:sub>SCI<\/jats:sub>\n                    ) and 92.5% with cognitive performance comparable to CV, HC, and PV (Mixed\n                    <jats:sub>(non-SCI)<\/jats:sub>\n                    ). The PCS\n                    <jats:sub>SCI<\/jats:sub>\n                    subgroup showed pronounced objective impairments, particularly in attentional, memory, and executive domains. Across the entire PCS sample, objective cognitive impairments were not predicted by fatigue severity or affective state (depression or anxiety), although lifetime psychiatric disorders and cognitive fatigue were significantly more prevalent in PCS\n                    <jats:sub>SCI<\/jats:sub>\n                    . Among patients with PCS, a distinct subgroup of individuals presents with severe cognitive deficits, significant cognitive fatigue, and an increased lifetime vulnerability for psychiatric disorders, highlighting the need for targeted diagnostic assessments and personalized (psycho-)therapeutic interventions.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-25453-y","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T10:58:40Z","timestamp":1763463520000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evidence for a severe cognitive subgroup in a comprehensive neuropsychological Post-COVID-19 syndrome classification"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8088-3386","authenticated-orcid":false,"given":"Luisa T.","family":"Balz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3003-4119","authenticated-orcid":false,"given":"Deborah K.","family":"Erhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Uttner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5944-398X","authenticated-orcid":false,"given":"Doroth\u00e9e E.","family":"Lul\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1647-6201","authenticated-orcid":false,"given":"Hayrettin","family":"Tumani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"25453_CR1","unstructured":"National Institute for Health and Care Excellence (NICE). COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: NICE; 2024 Jan 25. Available from: https:\/\/www.nice.org.uk\/guidance\/ng188. PMID: 33555768."},{"issue":"12","key":"25453_CR2","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1055\/s-0043-1777115","volume":"81","author":"GC Cipolli","year":"2023","unstructured":"Cipolli, G. C. et al. Cognitive impairment in post-acute COVID-19 syndrome: a scoping review. Arq. Neuropsiquiatr. 81 (12), 1053\u20131069 (2023).","journal-title":"Arq. Neuropsiquiatr."},{"issue":"8","key":"25453_CR3","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1007\/s00415-022-11141-8","volume":"269","author":"M Calabria","year":"2022","unstructured":"Calabria, M. et al. Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms. J. Neurol. 269 (8), 3990\u20133999 (2022).","journal-title":"J. Neurol."},{"issue":"5","key":"25453_CR4","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/alz.12644","volume":"18","author":"L Crivelli","year":"2022","unstructured":"Crivelli, L. et al. Changes in cognitive functioning after COVID-19: A systematic review and meta-analysis. Alzheimers Dement. 18 (5), 1047\u20131066 (2022).","journal-title":"Alzheimers Dement."},{"key":"25453_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bbi.2021.12.020","volume":"101","author":"F Ceban","year":"2022","unstructured":"Ceban, F. et al. Fatigue and cognitive impairment in Post-COVID-19 syndrome: A systematic review and meta-analysis. Brain Behav. Immun. 101, 93\u2013135 (2022).","journal-title":"Brain Behav. Immun."},{"key":"25453_CR6","doi-asserted-by":"publisher","first-page":"p80","DOI":"10.1016\/j.genhosppsych.2022.07.013","volume":"78","author":"S Lynch","year":"2022","unstructured":"Lynch, S. et al. Screening for brain fog: is the Montreal cognitive assessment an effective screening tool for neurocognitive complaints post-COVID-19? Gen. Hosp. Psychiatry. 78, p80\u201386 (2022).","journal-title":"Gen. Hosp. Psychiatry"},{"key":"25453_CR7","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1001\/jamapsychiatry.2023.2820","volume":"80","author":"JH Becker","year":"2023","unstructured":"Becker, J. H., Vannorsdall, T. D. & Weisenbach, S. L. Evaluation of Post\u2013COVID-19 cognitive dysfunction: recommendations for researchers. JAMA Psychiatry. 80, 1085\u20131086 (2023).","journal-title":"JAMA Psychiatry"},{"key":"25453_CR8","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1001\/jama.2022.18931","volume":"328","author":"G Collaborators","year":"2022","unstructured":"Collaborators, G. Estimated global proportions of individuals with persistent Fatigue, Cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA 328, 1604\u20131615 (2022).","journal-title":"JAMA"},{"issue":"7","key":"25453_CR9","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s40263-022-00931-3","volume":"36","author":"MG Mazza","year":"2022","unstructured":"Mazza, M. G. et al. Post-COVID-19 depressive symptoms: Epidemiology, Pathophysiology, and Pharmacological treatment. CNS Drugs. 36 (7), 681\u2013702 (2022).","journal-title":"CNS Drugs"},{"key":"25453_CR10","doi-asserted-by":"publisher","first-page":"1029842","DOI":"10.3389\/fnagi.2022.1029842","volume":"14","author":"M Ariza","year":"2022","unstructured":"Ariza, M. et al. Neuropsychological impairment in post-COVID condition individuals with and without cognitive complaints. Front. Aging Neurosci. 14, 1029842 (2022).","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"25453_CR11","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s00415-022-11444-w","volume":"270","author":"AK Schild","year":"2023","unstructured":"Schild, A. K. et al. Multidomain cognitive impairment in non-hospitalized patients with the post-COVID-19 syndrome: results from a prospective monocentric cohort. J. Neurol. 270 (3), 1215\u20131223 (2023).","journal-title":"J. Neurol."},{"issue":"2","key":"25453_CR12","doi-asserted-by":"publisher","first-page":"e2356098","DOI":"10.1001\/jamanetworkopen.2023.56098","volume":"7","author":"A Jaywant","year":"2024","unstructured":"Jaywant, A. et al. Cognitive symptoms of Post-COVID-19 condition and daily functioning. JAMA Netw. Open. 7 (2), e2356098 (2024).","journal-title":"JAMA Netw. Open."},{"key":"25453_CR13","doi-asserted-by":"publisher","first-page":"100587","DOI":"10.1016\/j.bbih.2023.100587","volume":"27","author":"RE Pihlaja","year":"2023","unstructured":"Pihlaja, R. E. et al. Associations of subjective and objective cognitive functioning after COVID-19: A six-month follow-up of ICU, ward, and home-isolated patients. Brain Behav. Immun. Health. 27, 100587 (2023).","journal-title":"Brain Behav. Immun. Health"},{"issue":"1","key":"25453_CR14","doi-asserted-by":"publisher","first-page":"13368","DOI":"10.1038\/s41598-024-62050-x","volume":"14","author":"AR Bland","year":"2024","unstructured":"Bland, A. R. et al. Profiles of objective and subjective cognitive function in Post-COVID Syndrome, COVID-19 recovered, and COVID-19 Naive individuals. Sci. Rep. 14 (1), 13368 (2024).","journal-title":"Sci. Rep."},{"issue":"11","key":"25453_CR15","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.tics.2023.08.008","volume":"27","author":"S Zhao","year":"2023","unstructured":"Zhao, S. et al. Effects of COVID-19 on cognition and brain health. Trends Cogn. Sci. 27 (11), 1053\u20131067 (2023).","journal-title":"Trends Cogn. Sci."},{"issue":"5","key":"25453_CR16","doi-asserted-by":"publisher","first-page":"e2311974","DOI":"10.1001\/jamanetworkopen.2023.11974","volume":"6","author":"TC Liu","year":"2023","unstructured":"Liu, T. C. et al. Perceived cognitive deficits in patients with symptomatic SARS-CoV-2 and their association with Post-COVID-19 condition. JAMA Netw. Open. 6 (5), e2311974 (2023).","journal-title":"JAMA Netw. Open."},{"key":"25453_CR17","doi-asserted-by":"publisher","first-page":"106349","DOI":"10.1016\/j.clineuro.2020.106349","volume":"200","author":"T Kubota","year":"2021","unstructured":"Kubota, T. & Kuroda, N. Exacerbation of neurological symptoms and COVID-19 severity in patients with preexisting neurological disorders and COVID-19: A systematic review. Clin. Neurol. Neurosurg. 200, 106349 (2021).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"25453_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jpsychires.2022.03.033","volume":"150","author":"C Delgado-Alonso","year":"2022","unstructured":"Delgado-Alonso, C. et al. Cognitive dysfunction associated with COVID-19: A comprehensive neuropsychological study. J. Psychiatr Res. 150, 40\u201346 (2022).","journal-title":"J. Psychiatr Res."},{"issue":"1","key":"25453_CR19","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1186\/s12879-024-10308-0","volume":"24","author":"A Avinir","year":"2024","unstructured":"Avinir, A. et al. Personality and neuropsychiatric symptoms in individuals diagnosed with long COVID. BMC Infect. Dis. 24 (1), 1449 (2024).","journal-title":"BMC Infect. Dis."},{"issue":"4","key":"25453_CR20","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","volume":"22","author":"JB Soriano","year":"2022","unstructured":"Soriano, J. B. et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 22 (4), e102\u2013e107 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"25453_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/BF01109053","volume":"2","author":"RW Elwood","year":"1991","unstructured":"Elwood, R. W. The Wechsler memory Scale-Revised: psychometric characteristics and clinical application. Neuropsychol. Rev. 2, 179\u2013201 (1991).","journal-title":"Neuropsychol. Rev."},{"key":"25453_CR22","unstructured":"Helmstaedter, C., Lendt, M. & Lux, S. Verbaler Lern-und Merk- f\u00e4higkeitstest: VLMT: Manual 1 edn (Hogrefe, 2001)."},{"key":"25453_CR23","first-page":"195","volume":"14","author":"T Merten","year":"2008","unstructured":"Merten, T. & Blaskewitz, N. Der Rey complex figure test and recognition trial in der klinischen praxis. Neuro Rehabil. 14, 195\u2013202 (2008).","journal-title":"Neuro Rehabil"},{"key":"25453_CR24","unstructured":"Zimmermann, P. & Fimm, B. Testbatterie Zur Aufmerksamkeitsprufung (TAP) (Psytest, 1992)."},{"key":"25453_CR25","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1177\/1352458517690821","volume":"23","author":"RHB Benedict","year":"2017","unstructured":"Benedict, R. H. B. et al. Validity of the symbol digit modalities test as a cognition performance outcome measure for multiple sclerosis. Mult Scler. 23, 721\u2013733 (2017).","journal-title":"Mult Scler."},{"key":"25453_CR26","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3389\/fpsyg.2014.00772","volume":"5","author":"Z Shao","year":"2014","unstructured":"Shao, Z. et al. What do verbal fluency tasks measure? Predictors of verbal fluency performance in older adults. Front. Psychol. 5, 772 (2014).","journal-title":"Front. Psychol."},{"key":"25453_CR27","doi-asserted-by":"publisher","first-page":"l1476","DOI":"10.1136\/bmj.l1476","volume":"365","author":"B Levis","year":"2019","unstructured":"Levis, B. et al. Accuracy of patient health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis. BMJ 365, l1476 (2019).","journal-title":"BMJ"},{"key":"25453_CR28","doi-asserted-by":"publisher","first-page":"972628","DOI":"10.3389\/fpsyt.2022.972628","volume":"13","author":"J Vrublevska","year":"2022","unstructured":"Vrublevska, J. et al. Validation of the generalized anxiety disorder scales (GAD-7 and GAD-2) in primary care settings in Latvia. Front. Psychiatry. 13, 972628 (2022).","journal-title":"Front. Psychiatry"},{"issue":"12","key":"25453_CR29","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1177\/1352458509348519","volume":"15","author":"IK Penner","year":"2009","unstructured":"Penner, I. K. et al. The fatigue scale for motor and cognition functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue. Mult Scler. 15 (12), 1509\u20131517 (2009).","journal-title":"Mult Scler."},{"key":"25453_CR30","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1055\/s-2007-986199","volume":"58","author":"A K\u00f6rner","year":"2008","unstructured":"K\u00f6rner, A. et al. Personality assessment with the NEO\u2009\u2013\u2009Five\u2009\u2013\u2009Factor inventory: the 30\u2009\u2013\u2009Item\u2009\u2013\u2009Short \u2013\u2009Version (NEO\u2009\u2013\u2009FFI\u2009\u2013\u200930). Psychother. Psych Med. 58, 238\u2013245 (2008).","journal-title":"Psychother. Psych Med."},{"key":"25453_CR31","unstructured":"Cohen, J. Statistical Power Analysis for the Behavioral Sciences 2nd edn (Lawrence Erlbaum Associates, 1988)."},{"issue":"4","key":"25453_CR32","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s40120-022-00395-z","volume":"11","author":"M Fleischer","year":"2022","unstructured":"Fleischer, M. et al. Post-COVID-19 syndrome is rarely associated with damage of the nervous system: findings from a prospective observational cohort study in 171 patients. Neurol. Ther. 11 (4), 1637\u20131657 (2022).","journal-title":"Neurol. Ther."},{"issue":"1","key":"25453_CR33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41398-023-02567-3","volume":"13","author":"K Bogaerts","year":"2023","unstructured":"Bogaerts, K. et al. Brain mediators of negative affect-induced physical symptom reporting in patients with functional somatic syndromes. Transl Psychiatry. 13 (1), 285 (2023).","journal-title":"Transl Psychiatry"},{"key":"25453_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000494954","volume":"44","author":"G Gainotti","year":"2019","unstructured":"Gainotti, G. History of anosognosia. Front. Neurol. Neurosci. 44, 75\u201382 (2019).","journal-title":"Front. Neurol. Neurosci."},{"key":"25453_CR35","doi-asserted-by":"publisher","first-page":"102436","DOI":"10.1016\/j.eclinm.2024.102436","volume":"68","author":"C Minotti","year":"2024","unstructured":"Minotti, C. et al. How does post COVID differ from other post-viral conditions in childhood and adolescence (0\u201320 years old)? A systematic review. EClinicalMedicine 68, 102436 (2024).","journal-title":"EClinicalMedicine"},{"key":"25453_CR36","doi-asserted-by":"crossref","unstructured":"Salzmann, S. et al. Assessment of psychosocial aspects in adults in post-COVID-19 condition: the EURONET-SOMA recommendations on core outcome domains for clinical and research use. BMC Med. 23 (2025).","DOI":"10.1186\/s12916-025-03927-0"},{"issue":"1","key":"25453_CR37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s00415-023-12069-3","volume":"271","author":"EM Martin","year":"2024","unstructured":"Martin, E. M. et al. Persistent cognitive slowing in post-COVID patients: longitudinal study over 6 months. J. Neurol. 271 (1), 46\u201358 (2024).","journal-title":"J. Neurol."},{"issue":"2","key":"25453_CR38","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s10787-023-01174-4","volume":"31","author":"C Thurner","year":"2023","unstructured":"Thurner, C. & Stengel, A. Long-COVID syndrome: physical-mental interplay in the spotlight. Inflammopharmacology 31 (2), 559\u2013564 (2023).","journal-title":"Inflammopharmacology"},{"issue":"1","key":"25453_CR39","doi-asserted-by":"publisher","first-page":"6378","DOI":"10.1038\/s41598-023-32939-0","volume":"13","author":"E Herrera","year":"2023","unstructured":"Herrera, E. et al. Cognitive impairment in young adults with post COVID-19 syndrome. Sci. Rep. 13 (1), 6378 (2023).","journal-title":"Sci. Rep."},{"key":"25453_CR40","doi-asserted-by":"publisher","first-page":"jrm25315","DOI":"10.2340\/jrm.v56.25315","volume":"56","author":"S Klinkhammer","year":"2024","unstructured":"Klinkhammer, S. et al. Prevalence and trajectories of neuropsychological post-COVID-19 symptoms in initially hospitalized patients. J. Rehabil Med. 56, jrm25315 (2024).","journal-title":"J. Rehabil Med."},{"issue":"1","key":"25453_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/arclin\/acac068","volume":"38","author":"P Voruz","year":"2023","unstructured":"Voruz, P. et al. Frequency of abnormally low neuropsychological scores in Post-COVID-19 syndrome: the Geneva COVID-COG cohort. Arch. Clin. Neuropsychol. 38 (1), 1\u201311 (2023).","journal-title":"Arch. Clin. Neuropsychol."},{"key":"25453_CR42","doi-asserted-by":"publisher","first-page":"120162","DOI":"10.1016\/j.jns.2022.120162","volume":"434","author":"L Premraj","year":"2022","unstructured":"Premraj, L. et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J. Neurol. Sci. 434, 120162 (2022).","journal-title":"J. Neurol. Sci."},{"issue":"10444","key":"25453_CR43","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1016\/S0140-6736(24)01242-X","volume":"403","author":"T Lancet","year":"2024","unstructured":"Lancet, T. Taking persistent physical symptoms seriously. Lancet 403 (10444), 2565 (2024).","journal-title":"Lancet"},{"issue":"2","key":"25453_CR44","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1016\/S2213-2600(22)00501-X","volume":"11","author":"C Saunders","year":"2023","unstructured":"Saunders, C., Sperling, S. & Bendstrup, E. A new paradigm is needed to explain long COVID. Lancet Respir Med. 11 (2), e12\u2013e13 (2023).","journal-title":"Lancet Respir Med."},{"issue":"10444","key":"25453_CR45","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1016\/S0140-6736(24)00623-8","volume":"403","author":"B Lowe","year":"2024","unstructured":"Lowe, B. et al. Persistent physical symptoms: definition, genesis, and management. Lancet 403 (10444), 2649\u20132662 (2024).","journal-title":"Lancet"},{"issue":"1","key":"25453_CR46","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s44192-025-00189-3","volume":"5","author":"N Aderinto","year":"2025","unstructured":"Aderinto, N. et al. COVID-19 and cognitive impairment: a review of the emerging evidence. Discov Ment Health. 5 (1), 56 (2025).","journal-title":"Discov Ment Health"},{"issue":"1","key":"25453_CR47","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1080\/13803395.2024.2312625","volume":"46","author":"DM Whiteside","year":"2024","unstructured":"Whiteside, D. M. et al. The relationship between performance validity testing, external incentives, and cognitive functioning in long COVID. J. Clin. Exp. Neuropsychol. 46 (1), 6\u201315 (2024).","journal-title":"J. Clin. Exp. Neuropsychol."}],"updated-by":[{"DOI":"10.1038\/s41598-025-33148-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25453-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25453-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25453-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T17:01:39Z","timestamp":1767114099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25453-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25453"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-25453-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-025-33148-7","URL":"https:\/\/doi.org\/10.1038\/s41598-025-33148-7","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Prof. Dr. Tumani received honoraria for acting as a consultant\/speaker and\/or for attending events sponsored by Alexion, Bayer, Biogen, Bristol-Myers Squibb, Celgene, Diamed, Fresenius, Fujirebio, GlaxoSmithKline, Horizon, Janssen-Cilag, Merck, Novartis, Roche, Sanofi-Genzyme, Siemens, Teva and Viatris. Prof. Dr. Lul\u00e9, PhD received honoraria for acting as a consultant\/speaker and\/or for attending events sponsored by Zambon. None of the funder(s)\/sponsor(s) had any role in the hereby presented study or manuscript. LTB, DKE and, IU declared no conflicts of interest.Prof. Dr. Lul\u00e9, PhD received honoraria for acting as a consultant\/speaker and\/or for attending events sponsored by Zambon. None of the funder(s)\/sponsor(s) had any role in the hereby presented study or manuscript.\u00a0LTB, DKE and, IU declared no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Ulm University (Ethics Code: 16\/23) on March 16, 2023. All participants provided written informed consent prior to their inclusion in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval\/consent"}}],"article-number":"40368"}}